Article · 10 Jul 2026
Short communicationPublished 29 Jul 2025
ANDA: Generics, Bioequivalence, Access, Innovation
Subjects
Pharmaceutical SciencesSimilar by topic
Article · 4 Mar 2025
Innovations in Clinical Trial Design to Improve Bioequivalence Assessments for Complex Generics
Review article · 2018
Generic Drugs, A Need to the Public: USA and India- Government Plans to Reduce the Price of ANDA and List of Generic Drugs Approved in Year 2018
Article · 30 Aug 2024
Balancing Innovation and Accessibility: The Role of Branded and Generic Drugs in Healthcare
Conference abstract
Overview of submission of summary Bioequivalence data for ANDAs
More from this journal
The newest in Pharmaceutical Regulatory Affairs: Open Access.
Article · 13 Feb 2026
Regulatory Scenario of Pharmaceuticals during COVID-19 Pandemic in India
Article · 11 Feb 2026
EU GMP Annex 1 of 2022: A View in Depth
Article · 11 Feb 2026
Standard Formats Used in Drug Regulatory Submissions and Software Used
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Emily R. Thorne”

